Your browser doesn't support javascript.
loading
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
Kahn, Ryan M; Ragupathi, Govind; Zhou, Qin C; Iasonos, Alexia; Kravetz, Sara; Hensley, Martee L; Konner, Jason A; Makker, Vicky; Tew, William P; Aghajanian, Carol; Sabbatini, Paul J; O'Cearbhaill, Roisin E.
  • Kahn RM; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ragupathi G; Melanoma and Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zhou QC; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Iasonos A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kravetz S; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
  • Hensley ML; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
  • Konner JA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Makker V; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
  • Tew WP; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Aghajanian C; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
  • Sabbatini PJ; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • O'Cearbhaill RE; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Cancer Immunol Immunother ; 72(1): 183-191, 2023 Jan.
Article en En | MEDLINE | ID: mdl-35779095

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Interleucina-8 Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Interleucina-8 Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article